PepGen (PEPG) Assets Average (2022 - 2026)
PepGen (PEPG) reported Assets Average of $165.1 million for Q1 2026, up 18.66% on a YoY basis from $139.1 million in Q1 2025, and down 9.28% sequentially from $182.0 million in Q4 2025.
PepGen (PEPG) Assets Average (2022 - 2026) Analysis & Trends
PepGen (PEPG) has 5 years of Assets Average data on file, last reported at $165.1 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 18.66% year-over-year to $165.1 million; the trailing twelve-month figure through Mar 2026 stood at $165.1 million (up 18.66% YoY), and the FY2025 full-year result was $162.4 million, up 10.5% from the prior year.
- Assets Average eased to $165.1 million in Q1 2026, from $182.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $219.6 million in Q3 2022 to a low of $114.8 million in Q2 2025.
- A 5-year average of $173.2 million and a median of $175.0 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average surged 51.89% in 2023 and tumbled 42.66% in 2025, its largest moves.
- Tracing PEPG's Assets Average over 5 years: stood at $213.0 million in 2022, then fell by 27.84% to $153.7 million in 2023, then increased by 4.49% to $160.6 million in 2024, then rose by 13.34% to $182.0 million in 2025, then fell by 9.28% to $165.1 million in 2026.
- Business Quant data shows PEPG's Assets Average at $165.1 million in Q1 2026, $182.0 million in Q4 2025, and $146.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 165.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165.10 Mn |
| Dec 31, 2025 | 181.98 Mn |
| Sep 30, 2025 | 146.15 Mn |
| Jun 30, 2025 | 114.82 Mn |
| Mar 31, 2025 | 139.14 Mn |
| Dec 31, 2024 | 160.56 Mn |
| Sep 30, 2024 | 181.87 Mn |
| Jun 30, 2024 | 200.26 Mn |
| Mar 31, 2024 | 175.03 Mn |
| Dec 31, 2023 | 153.66 Mn |
| Sep 30, 2023 | 173.18 Mn |
| Jun 30, 2023 | 191.56 Mn |
| Mar 31, 2023 | 209.24 Mn |
| Dec 31, 2022 | 212.95 Mn |
| Sep 30, 2022 | 219.63 Mn |
| Jun 30, 2022 | 181.34 Mn |
| Mar 31, 2022 | 137.76 Mn |